Bortezomib in the Treatment of Multiple Myeloma

de

, ,

Éditeur :

Springer


Collection :

Milestones in Drug Therapy

Paru le : 2010-10-20

eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Lecture en ligne (streaming)
94,94

Téléchargement immédiat
Dès validation de votre commande
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description
Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promising anticancer drug targeting the proteasome. This proteasome inhibitor induces cell stress and apoptosis in the cancer cells. While multiple mechanisms are likely to be involved, proteasome inhibition may prevent the degradation of pro-apoptotic factors, permitting activation of programmed cell death in neoplastic cells dependent upon the suppression of proapoptotic pathways. This monograph on bortezomib is a valuable source of information for researchers and clinicians from the fields of oncology and pharmacology, working either in academia or the pharmaceutical industry.
Pages
180 pages
Collection
Milestones in Drug Therapy
Parution
2010-10-20
Marque
Springer
EAN papier
9783034800990
EAN EPUB
9783764389482

Informations sur l'ebook
Nombre pages copiables
1
Nombre pages imprimables
18
Taille du fichier
942 Ko
Prix
94,94 €